GlobeNewswire
-
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
26/08/2026 -
BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM
26/08/2026 -
Eikon Therapeutics to Participate in Investor Conferences in September 2026
26/08/2026 -
MicrobiotiX Completes Sentinel Cohort of its First-in-human Clinical Trial of MP101 for Pneumonia
26/08/2026 -
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
26/08/2026 -
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
26/08/2026 -
Wellness Together and TadHealth Partner to Expand Student Behavioral Health Support Through CYBHI
26/08/2026 -
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
26/08/2026 -
Ligand to Participate in September Investor Conferences
26/08/2026 -
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
26/08/2026 -
Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience
26/08/2026 -
Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society
26/08/2026 -
Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
26/08/2026 -
SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board
26/08/2026 -
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
26/08/2026 -
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
26/08/2026 -
Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer
26/08/2026 -
NOMAD Power Solutions, Inc. Receives DOE Authorization to Advance Vermont Long-Duration Energy Storage Project into Phase 3
26/08/2026 -
IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001
26/08/2026
Pages